Active and placebo granules were indistinguishable. Treatment Participants were prescribed 30 mg/kg/day of mesalazine or placebo in three divided doses for the first seven days. Then, if tolerated (see below), the dosage was increased to 45 mg/kg/day for a further 21 days. They were ...